Cargando…
AJAP1 expression modulates glioma cell motility and correlates with tumor growth and survival
Glioblastoma multiforme (GBM) is one of the most common primary malignant brain tumors. Unraveling the molecular and genetic complexity that determines GBM's pronounced migratory property could provide new options for therapeutic targeting that may significantly complement current surgical and...
Autores principales: | Di, Chunhui, Mladkova, Nikol, Lin, James, Fee, Brian, Rivas, Miriam, Chunsheng, Kang, Bigner, Darell, Adamson, David Cory |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743336/ https://www.ncbi.nlm.nih.gov/pubmed/29115565 http://dx.doi.org/10.3892/ijo.2017.4184 |
Ejemplares similares
-
Tumor-associated methylation of the putative tumor suppressor AJAP1 gene and association between decreased AJAP1 expression and shorter survival in patients with glioma
por: Cogdell, David, et al.
Publicado: (2011) -
Glioblastoma Multiforme Oncogenomics and Signaling Pathways
por: Kanu, Okezie O., et al.
Publicado: (2009) -
Endogenous AJAP1 associates with the cytoskeleton and attenuates angiogenesis in endothelial cells
por: Hötte, Katharina, et al.
Publicado: (2017) -
Expression Patterns of Ezrin and AJAP1 and Clinical Significance in Breast Cancer
por: Xu, Cong, et al.
Publicado: (2022) -
A novel recombinant immunotoxin-based therapy targeting wild-type and mutant EGFR improves survival in murine models of glioblastoma
por: Chandramohan, Vidyalakshmi, et al.
Publicado: (2013)